Susan Tran, DO
Family Practice · Los Gatos
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 12
- 1 carrier
- Office
- 1
Offices
1 location · University Healthcare Alliance · 334 clinicians in this group
Looking this up.
Hospitals listed: Good Samaritan Hospital · Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
12 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Tran’s office at (408) 426-5540 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Good Samaritan HospitalSan Jose, CAAcute Care Hospital · Proprietary · Has an emergency department · Birthing-friendlyPart of HCA Healthcare, which runs 185 hospitals in 19 statesPatients rate it 2 of 5 · 67% would definitely recommend itOverall rating: 2 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.337, Oct 2024 – Sep 2025
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Good Samaritan Hospital
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 1 worse of 8 measures. Readmissions: 0 better, 5 the same, 4 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.337 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.75 (0 to 1.67) · 1,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.84 (0.54 to 1.14) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 143.59 (98.7 to 188.49) · 98 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.7 · 45 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 100 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.7 · 270 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.3 · 573 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.6 · 820 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.5 · 482 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.3 · 3,711 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.12 (0 to 0.3) · 8,866 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.2 (0.01 to 0.38) · 9,051 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.65 (0.74 to 4.56) · 1,929 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.8 (0.21 to 3.39) · 670 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.33 (0.88 to 3.78) · 1,836 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 6.73 (0 to 13.46) · 669 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.58 (3.96 to 11.19) · 654 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.59 (0.13 to 3.04) · 496 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.27 (0 to 0.87) · 7,373 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.1 · 152 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 1.08 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.542 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.484 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.565 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.8 · 327 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 24.2 · 703 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 61.1 · 289 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 36.3 · 665 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 25.4 · 856 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 19 · 978 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.3 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 12.3 · 46 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 21.2 · 135 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.8 (10.1 to 18.6) · 129 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.2 (0.9 to 1.5) · 531 cases | No different | Jan 2024 – Dec 2024 |
What patients said (704 patients answered, 24% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 2 |
| Quietness | 1 |
| Recommend hospital | 3 |
| Room was "always" clean | 66% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 71% |
| Staff "always" explained | 54% |
| Yes, staff "did" give patients this information | 83% |
| Yes, staff "did" give patients information about help after discharge | 81% |
| Doctors "always" explained things so they could understand | 66% |
| Doctors "always" listened carefully | 69% |
| Doctors "always" treated them with courtesy and respect | 78% |
| Patients who gave a rating of "9" or "10" (high) | 63% |
| Staff "always" explained new medications | 68% |
| Nurses "always" explained things so they could understand | 69% |
| Nurses "always" listened carefully | 73% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 38% |
| "YES", patients would definitely recommend the hospital | 67% |
| Staff "always" explained possible side effects | 40% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$98,710
Medicare paid this office $98,710 for 223 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 207 | $55,999 | $107 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 98 | $15,002 | $153 |
| Long return visit (40+ min) | 40 | $8,620 | $166 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 184 | $6,044 | $14 |
| New patient visit (45+ min) | 18 | $2,207 | $123 |
See all 8 services
| Return visit (30+ min) | 207 | $55,999 | $107 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 98 | $15,002 | $153 |
| Long return visit (40+ min) | 40 | $8,620 | $166 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 184 | $6,044 | $14 |
| New patient visit (45+ min) | 18 | $2,207 | $123 |
| Influenza vaccine split virus, preservative free | 24 | $1,964 | $82 |
| Short return visit (20+ min) | 13 | $969 | $75 |
| Administration of influenza virus vaccine | 25 | $956 | $38 |
Who their Medicare patients are
223 Original Medicare patients in 2024. Average age 74 · Women 75% · Health risk score 1.13. At or below the middle of the specialty; the typical family practice clinician is at 1.13.
Conditions among them: High blood pressure 65% · Depression 22% · Diabetes 21% · Coronary heart disease 21% · Cancer 18% · Chronic kidney disease 16% · Atrial fibrillation 12% · Heart failure 11% · Stroke 8% · COPD 7% · Dementia 5%.
The office billed $352,129, Medicare allowed $130,743 and paid $98,710; for 1,339 services of 30 kinds; $4,771 of it was for drugs given in the office and $93,939 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 223 | 1,339 | 74 | 1.13 | $352,129 | $98,710 |
| 2023 | 219 | 739 | 75 | 1.12 | $285,413 | $82,855 |
| 2022 | 233 | 786 | 74 | 1.03 | $286,081 | $86,184 |
| 2021 | 227 | 696 | 74 | 1.02 | $290,351 | $82,561 |
| 2020 | 153 | 335 | 73 | 1.04 | $123,032 | $28,319 |
| 2019 | 135 | 396 | 74 | 1.12 | $129,887 | $32,048 |
| 2018 | 175 | 607 | 73 | 1.00 | $179,093 | $43,468 |
| 2017 | 156 | 588 | 74 | 1.13 | $144,182 | $39,148 |
| 2016 | 130 | 376 | 76 | 1.11 | $93,293 | $25,387 |
| 2015 | 121 | 350 | 73 | 1.18 | $68,726 | $25,605 |
| 2014 | 15 | 25 | 73 | 1.41 | $4,074 | $1,449 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 7 services
| Return visit (30+ min) | 190 | $49,451 | $108 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 64 | $9,978 | $156 |
| Long return visit (40+ min) | 46 | $9,740 | $162 |
| New patient visit (45+ min) | 20 | $3,053 | $153 |
| Short return visit (20+ min) | 26 | $2,206 | $82 |
| Influenza vaccine split virus, preservative free | 15 | $1,079 | $72 |
| Administration of influenza virus vaccine | 15 | $554 | $37 |
2022: 7 services
| Return visit (30+ min) | 184 | $54,605 | $113 |
| Long return visit (40+ min) | 37 | $8,012 | $170 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 46 | $7,275 | $158 |
| New patient visit (45+ min) | 19 | $2,947 | $155 |
| Short return visit (20+ min) | 28 | $2,636 | $82 |
| Influenza vaccine split virus, preservative free | 32 | $2,193 | $69 |
| Administration of influenza virus vaccine | 32 | $1,191 | $37 |
2021: 7 services
| Return visit (30+ min) | 186 | $52,547 | $117 |
| Long return visit (40+ min) | 39 | $8,939 | $169 |
| New patient visit (45+ min) | 41 | $6,624 | $162 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 40 | $6,545 | $164 |
| Telephone medical discussion with physician, 11-20 minutes | 17 | $2,053 | $71 |
| Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | 11 | $797 | $53 |
| Administration of influenza virus vaccine | 11 | $241 | $22 |
2020: 6 services
| Return visit (30+ min) | 128 | $19,650 | $92 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 15 | $2,147 | $143 |
| Telephone medical discussion with physician, 11-20 minutes | 17 | $1,604 | $73 |
| Influenza vaccine split virus, preservative free | 12 | $720 | $60 |
| Short return visit (20+ min) | 12 | $663 | $55 |
| Administration of influenza virus vaccine | 13 | $271 | $21 |
2019: 7 services
| Return visit (30+ min) | 118 | $21,037 | $100 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 20 | $2,834 | $142 |
| Influenza vaccine split virus, preservative free | 37 | $2,031 | $55 |
| Pneumococcal vaccine, 23-valent | 12 | $1,343 | $112 |
| Administration of influenza virus vaccine | 39 | $800 | $21 |
| Short return visit (20+ min) | 11 | $734 | $67 |
| Administration of pneumococcal vaccine | 18 | $369 | $21 |
2018: 9 services
| Return visit (30+ min) | 150 | $28,328 | $88 |
| Pneumococcal vaccine, 13-valent | 12 | $2,363 | $197 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 16 | $2,246 | $140 |
| Short return visit (20+ min) | 36 | $2,188 | $50 |
| Influenza vaccine split virus, preservative free | 35 | $1,826 | $52 |
| Pneumococcal vaccine, 23-valent | 14 | $1,478 | $106 |
| Administration of influenza virus vaccine | 39 | $1,003 | $26 |
| Administration of pneumococcal vaccine | 26 | $669 | $26 |
| Urinalysis, manual test | 11 | $68 | $3 |
2017: 10 services
| Return visit (30+ min) | 85 | $12,692 | $85 |
| Short return visit (20+ min) | 102 | $11,890 | $67 |
| New patient visit (30+ min) | 35 | $3,087 | $88 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 13 | $1,801 | $139 |
| Influenza vaccine split virus, preservative free | 37 | $1,778 | $48 |
| Administration of influenza virus vaccine | 38 | $1,227 | $32 |
| Pneumococcal vaccine, 23-valent | 12 | $1,145 | $95 |
| Administration of pneumococcal vaccine | 20 | $678 | $32 |
| Removal of impacted ear wax by washing | 11 | $154 | $14 |
| Urinalysis, manual test | 13 | $55 | $3 |
2016: 8 services
| Return visit (30+ min) | 76 | $13,855 | $88 |
| Pneumococcal vaccine, 13-valent | 11 | $1,936 | $176 |
| New patient visit (30+ min) | 22 | $1,898 | $86 |
| Short return visit (20+ min) | 32 | $1,862 | $50 |
| New patient visit (15+ min) | 12 | $706 | $59 |
| Influenza vaccine split virus, preservative free | 16 | $639 | $40 |
| Administration of influenza virus vaccine | 16 | $507 | $32 |
| Administration of pneumococcal vaccine | 15 | $461 | $31 |
2015: 7 services
| Return visit (30+ min) | 65 | $7,400 | $80 |
| Short return visit (20+ min) | 37 | $3,173 | $57 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 13 | $1,783 | $137 |
| Initial nursing facility care with moderate level of medical decision making, per day at least 35 minutes | 11 | $1,304 | $119 |
| New patient visit (30+ min) | 12 | $710 | $59 |
| Administration of influenza virus vaccine | 11 | $270 | $25 |
| Insertion of needle into vein for collection of blood sample | 19 | $76 | $3 |
Drugs they prescribed that Part D paid
$114,110
Pharmacies billed $114,110 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 2% of their Part D prescriptions (43 of 1,759) in 2024. Above the middle of the specialty; the typical family practice clinician is at 2%.
1,610 generic and 149 brand-name prescriptions · $114,110 in drug cost · 44 antibiotic prescriptions to 34 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Ozempic | 31 | $34,314 | $1,107 |
| Eliquis | 14 | $8,724 | $623 |
| Atorvastatin | 191 | $1,427 | $7 |
| Celecoxib | 19 | $1,150 | $61 |
| Gabapentin | 35 | $861 | $25 |
See all 44 drugs
| Ozempic | 31 | $34,314 | $1,107 |
| Eliquis | 14 | $8,724 | $623 |
| Atorvastatin | 191 | $1,427 | $7 |
| Celecoxib | 19 | $1,150 | $61 |
| Gabapentin | 35 | $861 | $25 |
| Levothyroxine | 87 | $775 | $9 |
| Bupropion Xl | 15 | $668 | $45 |
| Albuterol Sulfate Hfa | 27 | $605 | $22 |
| Pravastatin | 40 | $562 | $14 |
| Rosuvastatin | 62 | $511 | $8 |
| Hydrocodone-Acetaminophen | 15 | $373 | $25 |
| Tamsulosin | 13 | $345 | $27 |
| Metoprolol | 21 | $322 | $15 |
| Omeprazole | 23 | $306 | $13 |
| Simvastatin | 46 | $303 | $7 |
| Chlorthalidone | 27 | $286 | $11 |
| Lisinopril | 58 | $282 | $5 |
| Amlodipine Besylate | 53 | $264 | $5 |
| Escitalopram | 20 | $242 | $12 |
| Losartan | 49 | $241 | $5 |
| Trazodone | 30 | $237 | $8 |
| Zolpidem | 29 | $233 | $8 |
| Montelukast | 23 | $229 | $10 |
| Hydrocortisone | 11 | $196 | $18 |
| Lorazepam | 22 | $191 | $9 |
| Sertraline | 29 | $188 | $6 |
| Ramipril | 11 | $177 | $16 |
| Fluticasone Propionate | 14 | $175 | $13 |
| Metformin Hcl Er | 16 | $155 | $10 |
| Alendronate | 27 | $154 | $6 |
| Metformin | 21 | $153 | $7 |
| Atenolol | 14 | $148 | $11 |
| Temazepam | 12 | $131 | $11 |
| Meloxicam | 11 | $117 | $11 |
| Lovastatin | 12 | $109 | $9 |
| Baclofen | 13 | $84 | $6 |
| Tramadol | 18 | $60 | $3 |
| Alprazolam | 19 | $57 | $3 |
| Hydrochlorothiazide | 29 | $52 | $2 |
| Citalopram Hbr | 12 | $42 | $4 |
| Azithromycin | 13 | $36 | $3 |
| Furosemide | 12 | $27 | $2 |
| Metoprolol | 14 | $23 | $2 |
| Clonazepam | 15 | $11 | $1 |
Year by year
| 2024 | 1,759 | 263 | 2% (43) | 8% | $114,110 |
| 2023 | 1,874 | 277 | 2% (28) | None | $117,182 |
| 2022 | 2,156 | 278 | 1% (20) | 9% | $122,947 |
| 2021 | 1,667 | 273 | 2% (27) | 9% | $88,831 |
| 2020 | 1,085 | 199 | None | 11% | $63,679 |
| 2019 | 863 | 163 | 2% (16) | 10% | $42,040 |
| 2018 | 1,237 | 222 | 3% (38) | None | $74,207 |
| 2017 | 955 | 174 | 4% (35) | 14% | $42,791 |
| 2016 | 875 | 139 | 2% (18) | None | $55,823 |
| 2015 | 432 | 80 | 3% (12) | None | $22,044 |
| 2014 | 133 | 28 | None | None | $2,464 |
| 2013 | 138 | 35 | 0% (0) | None | $2,736 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 43 drugs
| Trulicity | 12 | $19,692 | $1,641 |
| Atorvastatin | 181 | $2,231 | $12 |
| Celecoxib | 12 | $1,492 | $124 |
| Levothyroxine | 97 | $1,431 | $15 |
| Synthroid | 12 | $1,285 | $107 |
| Rosuvastatin | 72 | $1,041 | $14 |
| Gabapentin | 44 | $905 | $21 |
| Chlorthalidone | 30 | $877 | $29 |
| Losartan | 56 | $781 | $14 |
| Lisinopril | 80 | $708 | $9 |
| Albuterol Sulfate Hfa | 21 | $632 | $30 |
| Alendronate | 47 | $550 | $12 |
| Potassium Chloride | 19 | $548 | $29 |
| Duloxetine | 11 | $492 | $45 |
| Pravastatin | 43 | $482 | $11 |
| Methadone | 11 | $454 | $41 |
| Trazodone | 38 | $449 | $12 |
| Metformin Hcl Er | 20 | $416 | $21 |
| Hydrocodone-Acetaminophen | 14 | $409 | $29 |
| Simvastatin | 48 | $405 | $8 |
| Tamsulosin | 21 | $391 | $19 |
| Metoprolol | 25 | $380 | $15 |
| Omeprazole | 30 | $340 | $11 |
| Amlodipine Besylate | 50 | $340 | $7 |
| Metformin | 24 | $269 | $11 |
| Zolpidem | 30 | $266 | $9 |
| Atenolol | 31 | $265 | $9 |
| Hydrochlorothiazide | 36 | $225 | $6 |
| Escitalopram | 19 | $221 | $12 |
| Baclofen | 15 | $196 | $13 |
| Fluticasone Propionate | 15 | $177 | $12 |
| Lovastatin | 12 | $170 | $14 |
| Pantoprazole | 21 | $169 | $8 |
| Sertraline | 19 | $166 | $9 |
| Montelukast | 15 | $163 | $11 |
| Lorazepam | 20 | $137 | $7 |
| Diphenoxylate-Atropine | 12 | $122 | $10 |
| Amoxicillin-Clavulanate Potass | 11 | $89 | $8 |
| Furosemide | 12 | $89 | $7 |
| Clonazepam | 17 | $82 | $5 |
| Meloxicam | 23 | $78 | $3 |
| Alprazolam | 18 | $53 | $3 |
| Azithromycin | 13 | $50 | $4 |
2022: 49 drugs
| Trulicity | 21 | $22,637 | $1,078 |
| Advair Diskus | 15 | $5,620 | $375 |
| Atorvastatin | 210 | $2,548 | $12 |
| Levothyroxine | 130 | $2,467 | $19 |
| Gabapentin | 56 | $1,178 | $21 |
| Rosuvastatin | 68 | $1,044 | $15 |
| Losartan | 73 | $984 | $13 |
| Albuterol Sulfate Hfa | 21 | $971 | $46 |
| Lisinopril | 102 | $792 | $8 |
| Chlorthalidone | 27 | $682 | $25 |
| Potassium Chloride | 17 | $545 | $32 |
| Pravastatin | 38 | $531 | $14 |
| Metoprolol | 34 | $500 | $15 |
| Valacyclovir | 11 | $494 | $45 |
| Alendronate | 50 | $474 | $9 |
| Pantoprazole | 32 | $459 | $14 |
| Amlodipine Besylate | 72 | $457 | $6 |
| Atenolol | 44 | $444 | $10 |
| Trazodone | 17 | $402 | $24 |
| Omeprazole | 32 | $373 | $12 |
| Escitalopram | 30 | $361 | $12 |
| Metformin | 33 | $353 | $11 |
| Tamsulosin | 25 | $332 | $13 |
| Simvastatin | 54 | $309 | $6 |
| Fluticasone Propionate | 14 | $301 | $22 |
| Nitrofurantoin Mono-Macro | 18 | $300 | $17 |
| Losartan-Hydrochlorothiazide | 13 | $296 | $23 |
| Metformin Hcl Er | 22 | $265 | $12 |
| Carvedilol | 16 | $264 | $16 |
| Ipratropium | 13 | $238 | $18 |
| Venlafaxine Hcl Er | 11 | $200 | $18 |
| Hydrochlorothiazide | 34 | $196 | $6 |
| Montelukast | 18 | $182 | $10 |
| Lovastatin | 14 | $182 | $13 |
| Triamterene-Hydrochlorothiazid | 16 | $180 | $11 |
| Zolpidem | 29 | $169 | $6 |
| Furosemide | 28 | $168 | $6 |
| Diclofenac | 13 | $154 | $12 |
| Amoxicillin-Clavulanate Potass | 15 | $148 | $10 |
| Allopurinol | 11 | $137 | $12 |
| Paroxetine | 11 | $134 | $12 |
| Temazepam | 22 | $130 | $6 |
| Ibuprofen | 12 | $90 | $7 |
| Sertraline | 13 | $89 | $7 |
| Clonazepam | 16 | $69 | $4 |
| Azithromycin | 11 | $67 | $6 |
| Alprazolam | 23 | $60 | $3 |
| Lorazepam | 21 | $42 | $2 |
| Meloxicam | 18 | $32 | $2 |
2021: 45 drugs
| Eliquis | 11 | $9,855 | $896 |
| Flovent Hfa | 16 | $4,649 | $291 |
| Levothyroxine | 104 | $2,709 | $26 |
| Atorvastatin | 139 | $2,681 | $19 |
| Rosuvastatin | 39 | $1,343 | $34 |
| Celecoxib | 16 | $789 | $49 |
| Losartan | 49 | $767 | $16 |
| Pravastatin | 38 | $738 | $19 |
| Gabapentin | 35 | $703 | $20 |
| Albuterol Sulfate Hfa | 13 | $688 | $53 |
| Valsartan-Hydrochlorothiazide | 13 | $645 | $50 |
| Omeprazole | 37 | $643 | $17 |
| Lisinopril | 67 | $553 | $8 |
| Valacyclovir | 12 | $399 | $33 |
| Tamsulosin | 23 | $394 | $17 |
| Simvastatin | 37 | $390 | $11 |
| Metoprolol | 18 | $380 | $21 |
| Pantoprazole | 30 | $380 | $13 |
| Amlodipine Besylate | 48 | $343 | $7 |
| Chlorthalidone | 11 | $331 | $30 |
| Losartan-Hydrochlorothiazide | 11 | $302 | $27 |
| Topiramate | 12 | $300 | $25 |
| Clopidogrel | 12 | $292 | $24 |
| Diclofenac | 13 | $282 | $22 |
| Alendronate | 33 | $282 | $9 |
| Nitrofurantoin Mono-Macro | 20 | $276 | $14 |
| Bupropion Xl | 13 | $253 | $19 |
| Atenolol | 25 | $248 | $10 |
| Escitalopram | 19 | $238 | $13 |
| Trazodone | 23 | $238 | $10 |
| Fluticasone Propionate | 17 | $214 | $13 |
| Metformin | 25 | $213 | $9 |
| Olmesartan Medoxomil | 12 | $204 | $17 |
| Triamterene-Hydrochlorothiazid | 11 | $203 | $18 |
| Lovastatin | 13 | $191 | $15 |
| Famotidine | 12 | $177 | $15 |
| Montelukast | 19 | $166 | $9 |
| Metformin Hcl Er | 13 | $160 | $12 |
| Zolpidem | 29 | $136 | $5 |
| Furosemide | 16 | $93 | $6 |
| Ibuprofen | 13 | $88 | $7 |
| Tramadol | 11 | $67 | $6 |
| Hydrochlorothiazide | 22 | $67 | $3 |
| Temazepam | 14 | $64 | $5 |
| Alprazolam | 20 | $34 | $2 |
2020: 25 drugs
| Atorvastatin | 100 | $1,744 | $17 |
| Levothyroxine | 60 | $1,686 | $28 |
| Rosuvastatin | 18 | $737 | $41 |
| Pravastatin | 25 | $691 | $28 |
| Valsartan-Hydrochlorothiazide | 11 | $640 | $58 |
| Losartan | 29 | $537 | $19 |
| Metoprolol | 24 | $478 | $20 |
| Simvastatin | 21 | $446 | $21 |
| Lisinopril | 47 | $360 | $8 |
| Gabapentin | 21 | $332 | $16 |
| Tamsulosin | 17 | $246 | $14 |
| Trazodone | 17 | $242 | $14 |
| Duloxetine | 12 | $242 | $20 |
| Carvedilol | 16 | $219 | $14 |
| Clopidogrel | 13 | $214 | $16 |
| Pantoprazole | 11 | $197 | $18 |
| Furosemide | 22 | $191 | $9 |
| Amlodipine Besylate | 35 | $189 | $5 |
| Omeprazole | 18 | $185 | $10 |
| Metformin | 24 | $172 | $7 |
| Atenolol | 14 | $147 | $10 |
| Alendronate | 16 | $143 | $9 |
| Lovastatin | 11 | $108 | $10 |
| Zolpidem | 12 | $66 | $6 |
| Alprazolam | 12 | $58 | $5 |
2019: 17 drugs
| Levothyroxine | 68 | $1,917 | $28 |
| Atorvastatin | 79 | $1,188 | $15 |
| Losartan | 30 | $513 | $17 |
| Doxazosin Mesylate | 15 | $495 | $33 |
| Tamsulosin | 24 | $442 | $18 |
| Simvastatin | 25 | $343 | $14 |
| Omeprazole | 22 | $313 | $14 |
| Gabapentin | 16 | $268 | $17 |
| Lisinopril | 37 | $257 | $7 |
| Valacyclovir | 11 | $251 | $23 |
| Alendronate | 17 | $232 | $14 |
| Metformin | 15 | $181 | $12 |
| Amlodipine Besylate | 21 | $171 | $8 |
| Hydrochlorothiazide | 15 | $158 | $11 |
| Trazodone | 11 | $136 | $12 |
| Atenolol | 12 | $107 | $9 |
| Furosemide | 16 | $104 | $7 |
2018: 27 drugs
| Atorvastatin | 98 | $1,909 | $19 |
| Levothyroxine | 67 | $1,785 | $27 |
| Oxycodone-Acetaminophen | 18 | $1,775 | $99 |
| Synthroid | 22 | $1,647 | $75 |
| Estradiol | 12 | $1,179 | $98 |
| Chlorthalidone | 15 | $795 | $53 |
| Esomeprazole Magnesium | 14 | $692 | $49 |
| Duloxetine | 13 | $616 | $47 |
| Lisinopril | 58 | $503 | $9 |
| Omeprazole | 29 | $468 | $16 |
| Losartan | 38 | $441 | $12 |
| Simvastatin | 30 | $338 | $11 |
| Alendronate | 28 | $327 | $12 |
| Potassium Chloride | 14 | $316 | $23 |
| Metoprolol | 13 | $303 | $23 |
| Levetiracetam | 11 | $266 | $24 |
| Gabapentin | 14 | $259 | $19 |
| Alprazolam | 31 | $238 | $8 |
| Losartan-Hydrochlorothiazide | 15 | $220 | $15 |
| Metformin | 22 | $205 | $9 |
| Trazodone | 26 | $187 | $7 |
| Amlodipine Besylate | 21 | $178 | $8 |
| Zolpidem | 24 | $148 | $6 |
| Hydrochlorothiazide | 19 | $136 | $7 |
| Atenolol | 17 | $129 | $8 |
| Metoprolol | 16 | $108 | $7 |
| Clonazepam | 15 | $95 | $6 |
2017: 24 drugs
| Chlorthalidone | 26 | $1,390 | $53 |
| Synthroid | 14 | $1,276 | $91 |
| Levothyroxine | 26 | $771 | $30 |
| Duloxetine | 18 | $689 | $38 |
| Metoprolol | 13 | $648 | $50 |
| Atorvastatin | 44 | $638 | $14 |
| Lisinopril | 37 | $466 | $13 |
| Quetiapine | 17 | $427 | $25 |
| Omeprazole | 21 | $227 | $11 |
| Losartan | 22 | $216 | $10 |
| Digoxin | 13 | $167 | $13 |
| Amlodipine Besylate | 25 | $156 | $6 |
| Simvastatin | 15 | $147 | $10 |
| Sumatriptan | 15 | $138 | $9 |
| Lorazepam | 21 | $137 | $7 |
| Azithromycin | 18 | $129 | $7 |
| Amoxicillin-Clavulanate Potass | 13 | $127 | $10 |
| Metformin | 11 | $96 | $9 |
| Alprazolam | 18 | $89 | $5 |
| Hydrochlorothiazide | 21 | $84 | $4 |
| Furosemide | 12 | $80 | $7 |
| Atenolol | 12 | $58 | $5 |
| Tramadol | 12 | $52 | $4 |
| Clonazepam | 12 | $28 | $2 |
2016: 28 drugs
| Tradjenta | 12 | $4,479 | $373 |
| Lantus Solostar | 17 | $4,304 | $253 |
| Potassium Chloride | 16 | $1,568 | $98 |
| Valsartan | 16 | $929 | $58 |
| Atorvastatin | 53 | $887 | $17 |
| Quetiapine | 17 | $607 | $36 |
| Levothyroxine | 17 | $522 | $31 |
| Flecainide Acetate | 12 | $343 | $29 |
| Metoprolol | 15 | $335 | $22 |
| Ranitidine | 14 | $333 | $24 |
| Gabapentin | 23 | $262 | $11 |
| Omeprazole | 15 | $229 | $15 |
| Lisinopril | 25 | $188 | $8 |
| Amlodipine Besylate | 27 | $182 | $7 |
| Alendronate | 18 | $166 | $9 |
| Pantoprazole | 12 | $148 | $12 |
| Fluticasone Propionate | 14 | $141 | $10 |
| Amoxicillin-Clavulanate Potass | 11 | $134 | $12 |
| Digoxin | 12 | $128 | $11 |
| Pioglitazone | 13 | $123 | $9 |
| Losartan | 19 | $116 | $6 |
| Metformin | 19 | $104 | $5 |
| Baclofen | 15 | $94 | $6 |
| Warfarin | 12 | $94 | $8 |
| Lorazepam | 13 | $60 | $5 |
| Furosemide | 19 | $45 | $2 |
| Glipizide | 11 | $43 | $4 |
| Alprazolam | 14 | $36 | $3 |
2015: 6 drugs
| Levothyroxine | 22 | $561 | $25 |
| Zolpidem | 11 | $233 | $21 |
| Metformin | 16 | $127 | $8 |
| Alendronate | 11 | $123 | $11 |
| Lisinopril | 12 | $105 | $9 |
| Amlodipine Besylate | 14 | $96 | $7 |
2014: 3 drugs
| Trinessa | 11 | $140 | $13 |
| Simvastatin | 15 | $86 | $6 |
| Metformin | 11 | $78 | $7 |
2013: 4 drugs
| Levothyroxine | 11 | $83 | $8 |
| Simvastatin | 12 | $80 | $7 |
| Amlodipine Besylate | 12 | $66 | $5 |
| Hydrochlorothiazide | 13 | $44 | $3 |
Money from drug and device companies
$125 in 2025
A payment is not proof that care is biased.
| Novo Nordisk | Ozempic | $125 | 1 payment
|
See the published payment
| Novo Nordisk | Meals · 2025-04-01 | Ozempic | $125 |
Professional record
- NPI
- 1962752600
- Licence
- CA 20A12499
- Trained
- Western University of Health Sciences College of Dental Med, 2011
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- Yes
- Taxonomy
- Family medicine (207Q00000X)
- Mailing address
- 1569 Lexann Ave, Suite 128, San Jose, CA, 95121
- NPI first listed
- 2012-09-10
- NPI last updated
- 2015-04-20
This is when the NPI record was last certified, not a medical board exam.